Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Identification of RUVBL1 and RUVBL2 as Novel Cellular Interactors of the Ebola Virus Nucleoprotein.

Morwitzer MJ, Tritsch SR, Cazares LH, Ward MD, Nuss JE, Bavari S, Reid SP.

Viruses. 2019 Apr 23;11(4). pii: E372. doi: 10.3390/v11040372.

2.

Characterization of the plasma proteome of nonhuman primates during Ebola virus disease or melioidosis: a host response comparison.

Ward MD, Brueggemann EE, Kenny T, Reitstetter RE, Mahone CR, Trevino S, Wetzel K, Donnelly GC, Retterer C, Norgren RB Jr, Panchal RG, Warren TK, Bavari S, Cazares LH.

Clin Proteomics. 2019 Feb 7;16:7. doi: 10.1186/s12014-019-9227-3. eCollection 2019.

3.

Bioengineering of bacterial pathogens for noninvasive imaging and in vivo evaluation of therapeutics.

Rajamani S, Kuszpit K, Scarff JM, Lundh L, Khan M, Brown J, Stafford R, Cazares LH, Panchal RG, Bocan T.

Sci Rep. 2018 Aug 22;8(1):12618. doi: 10.1038/s41598-018-30806-x.

4.

Countering Zika Virus: The USAMRIID Response.

Lowen RG, Bocan TM, Kane CD, Cazares LH, Kota KP, Ladner JT, Nasar F, Pitt L, Smith DR, Soloveva V, Sun MG, Zeng X, Bavari S.

Adv Exp Med Biol. 2018;1062:303-318. doi: 10.1007/978-981-10-8727-1_21. Review.

PMID:
29845541
5.

New Steroidal 4-Aminoquinolines Antagonize Botulinum Neurotoxin Serotype A in Mouse Embryonic Stem Cell Derived Motor Neurons in Postintoxication Model.

Konstantinović J, Kiris E, Kota KP, Kugelman-Tonos J, Videnović M, Cazares LH, Terzić Jovanović N, Verbić TŽ, Andjelković B, Duplantier AJ, Bavari S, Šolaja BA.

J Med Chem. 2018 Feb 22;61(4):1595-1608. doi: 10.1021/acs.jmedchem.7b01710. Epub 2018 Feb 6.

6.

Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus.

Bixler SL, Bocan TM, Wells J, Wetzel KS, Van Tongeren SA, Dong L, Garza NL, Donnelly G, Cazares LH, Nuss J, Soloveva V, Koistinen KA, Welch L, Epstein C, Liang LF, Giesing D, Lenk R, Bavari S, Warren TK.

Antiviral Res. 2018 Mar;151:97-104. doi: 10.1016/j.antiviral.2017.12.021. Epub 2017 Dec 28.

7.

Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus.

Bixler SL, Bocan TM, Wells J, Wetzel KS, Van Tongeren SA, Garza NL, Donnelly G, Cazares LH, Soloveva V, Welch L, Epstein C, Liang LF, Giesing D, Lenk R, Bavari S, Warren TK.

Antiviral Res. 2018 Mar;151:50-54. doi: 10.1016/j.antiviral.2017.12.020. Epub 2017 Dec 28.

8.

Chikungunya Arthritis Mechanisms in the Americas: A Cross-Sectional Analysis of Chikungunya Arthritis Patients Twenty-Two Months After Infection Demonstrating No Detectable Viral Persistence in Synovial Fluid.

Chang AY, Martins KAO, Encinales L, Reid SP, Acuña M, Encinales C, Matranga CB, Pacheco N, Cure C, Shukla B, Ruiz Arteta T, Amdur R, Cazares LH, Gregory M, Ward MD, Porras A, Rico Mendoza A, Dong L, Kenny T, Brueggemann E, Downey LG, Kamalapathy P, Lichtenberger P, Falls O, Simon GL, Bethony JM, Firestein GS.

Arthritis Rheumatol. 2018 Apr;70(4):585-593. doi: 10.1002/art.40383. Epub 2018 Mar 7.

9.

CCL5-CCR5 interactions modulate metabolic events during tumor onset to promote tumorigenesis.

Gao D, Cazares LH, Fish EN.

BMC Cancer. 2017 Dec 8;17(1):834. doi: 10.1186/s12885-017-3817-0.

10.

High Infection Rates for Adult Macaques after Intravaginal or Intrarectal Inoculation with Zika Virus.

Haddow AD, Nalca A, Rossi FD, Miller LJ, Wiley MR, Perez-Sautu U, Washington SC, Norris SL, Wollen-Roberts SE, Shamblin JD, Kimmel AE, Bloomfield HA, Valdez SM, Sprague TR, Principe LM, Bellanca SA, Cinkovich SS, Lugo-Roman L, Cazares LH, Pratt WD, Palacios GF, Bavari S, Pitt ML, Nasar F.

Emerg Infect Dis. 2017 Aug;23(8):1274-1281. doi: 10.3201/eid2308.170036. Epub 2017 Aug 15.

11.

Inactivation of West Nile virus in serum with heat, ionic detergent, and reducing agent for proteomic applications.

Altamura LA, Cazares LH, Coyne SR, Jaissle JG, Jespersen AM, Ahmed S, Wasieloski LP, Garrison J, Kulesh DA, Brueggemann EE, Kenny T, Ward MD, Harbourt DE, Minogue TD.

J Virol Methods. 2017 Oct;248:1-6. doi: 10.1016/j.jviromet.2017.05.010. Epub 2017 May 19.

12.

Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring.

Liu C, Zhao Z, Fan J, Lyon CJ, Wu HJ, Nedelkov D, Zelazny AM, Olivier KN, Cazares LH, Holland SM, Graviss EA, Hu Y.

Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3969-3974. doi: 10.1073/pnas.1621360114. Epub 2017 Mar 27.

13.

Development of a liquid chromatography high resolution mass spectrometry method for the quantitation of viral envelope glycoprotein in Ebola virus-like particle vaccine preparations.

Cazares LH, Ward MD, Brueggemann EE, Kenny T, Demond P, Mahone CR, Martins KA, Nuss JE, Glaros T, Bavari S.

Clin Proteomics. 2016 Sep 5;13(1):18. doi: 10.1186/s12014-016-9119-8. eCollection 2016.

14.

A Multicomponent Animal Virus Isolated from Mosquitoes.

Ladner JT, Wiley MR, Beitzel B, Auguste AJ, Dupuis AP 2nd, Lindquist ME, Sibley SD, Kota KP, Fetterer D, Eastwood G, Kimmel D, Prieto K, Guzman H, Aliota MT, Reyes D, Brueggemann EE, St John L, Hyeroba D, Lauck M, Friedrich TC, O'Connor DH, Gestole MC, Cazares LH, Popov VL, Castro-Llanos F, Kochel TJ, Kenny T, White B, Ward MD, Loaiza JR, Goldberg TL, Weaver SC, Kramer LD, Tesh RB, Palacios G.

Cell Host Microbe. 2016 Sep 14;20(3):357-367. doi: 10.1016/j.chom.2016.07.011. Epub 2016 Aug 25.

15.

Sphingosine kinase 2 is a chikungunya virus host factor co-localized with the viral replication complex.

Reid SP, Tritsch SR, Kota K, Chiang CY, Dong L, Kenny T, Brueggemann EE, Ward MD, Cazares LH, Bavari S.

Emerg Microbes Infect. 2015 Oct;4(10):e61. doi: 10.1038/emi.2015.61. Epub 2015 Oct 14.

16.

Thermal inactivation of enzymes and pathogens in biosamples for MS analysis.

Ahnoff M, Cazares LH, Sköld K.

Bioanalysis. 2015;7(15):1885-99. doi: 10.4155/bio.15.122.

PMID:
26295989
17.

Heat fixation inactivates viral and bacterial pathogens and is compatible with downstream MALDI mass spectrometry tissue imaging.

Cazares LH, Van Tongeren SA, Costantino J, Kenny T, Garza NL, Donnelly G, Lane D, Panchal RG, Bavari S.

BMC Microbiol. 2015 May 13;15:101. doi: 10.1186/s12866-015-0431-7.

18.

Pre-symptomatic diagnosis and treatment of filovirus diseases.

Shurtleff AC, Whitehouse CA, Ward MD, Cazares LH, Bavari S.

Front Microbiol. 2015 Feb 20;6:108. doi: 10.3389/fmicb.2015.00108. eCollection 2015. Review.

19.

MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma.

Jones EE, Powers TW, Neely BA, Cazares LH, Troyer DA, Parker AS, Drake RR.

Proteomics. 2014 Apr;14(7-8):924-35. doi: 10.1002/pmic.201300434. Epub 2014 Mar 3.

20.

Characterization of a Staphylococcus aureus USA300 protein signature using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Boggs SR, Cazares LH, Drake R.

J Med Microbiol. 2012 May;61(Pt 5):640-4. doi: 10.1099/jmm.0.037978-0. Epub 2012 Feb 9.

PMID:
22322338
21.

Molecular pathology of prostate cancer.

Cazares LH, Drake RR, Esquela-Kirscher A, Lance RS, Semmes OJ, Troyer DA.

Cancer Biomark. 2010;9(1-6):441-59. doi: 10.3233/CBM-2011-0181. Review.

PMID:
22112489
22.

Using boronolectin in MALDI-MS imaging for the histological analysis of cancer tissue expressing the sialyl Lewis X antigen.

Dai C, Cazares LH, Wang L, Chu Y, Wang SL, Troyer DA, Semmes OJ, Drake RR, Wang B.

Chem Commun (Camb). 2011 Oct 7;47(37):10338-40. doi: 10.1039/c1cc11814e. Epub 2011 Aug 19.

PMID:
21853197
23.

Improved signal processing and normalization for biomarker protein detection in broad-mass-range TOF mass spectra from clinical samples.

Tracy MB, Cooke WE, Gatlin CL, Cazares LH, Weaver DM, Semmes OJ, Tracy ER, Manos DM, Malyarenko DI.

Proteomics Clin Appl. 2011 Aug;5(7-8):440-7. doi: 10.1002/prca.201000095. Epub 2011 Jul 13.

24.

On-tissue identification of insulin: in situ reduction coupled with mass spectrometry imaging.

Green-Mitchell SM, Cazares LH, Semmes OJ, Nadler JL, Nyalwidhe JO.

Proteomics Clin Appl. 2011 Aug;5(7-8):448-53. doi: 10.1002/prca.201000152. Epub 2011 Jun 8.

25.

MALDI tissue imaging: from biomarker discovery to clinical applications.

Cazares LH, Troyer DA, Wang B, Drake RR, Semmes OJ.

Anal Bioanal Chem. 2011 Jul;401(1):17-27. doi: 10.1007/s00216-011-5003-6. Epub 2011 May 4. Review.

26.

Challenges to developing proteomic-based breast cancer diagnostics.

Drake RR, Cazares LH, Jones EE, Fuller TW, Semmes OJ, Laronga C.

OMICS. 2011 May;15(5):251-9. doi: 10.1089/omi.2010.0120. Epub 2011 Feb 19. Review.

27.

A Bayesian network approach to feature selection in mass spectrometry data.

Kuschner KW, Malyarenko DI, Cooke WE, Cazares LH, Semmes OJ, Tracy ER.

BMC Bioinformatics. 2010 Apr 8;11:177. doi: 10.1186/1471-2105-11-177.

28.

Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue.

Cazares LH, Troyer D, Mendrinos S, Lance RA, Nyalwidhe JO, Beydoun HA, Clements MA, Drake RR, Semmes OJ.

Clin Cancer Res. 2009 Sep 1;15(17):5541-51. doi: 10.1158/1078-0432.CCR-08-2892. Epub 2009 Aug 18.

29.

Proteomic expression profiling and identification of serum proteins using immobilized trypsin beads with MALDI-TOF/TOF.

Karbassi ID, Nyalwidhe JO, Wilkins CE, Cazares LH, Lance RS, Semmes OJ, Drake RR.

J Proteome Res. 2009 Sep;8(9):4182-92. doi: 10.1021/pr800836c.

PMID:
19603828
30.

Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients.

Schaub NP, Jones KJ, Nyalwidhe JO, Cazares LH, Karbassi ID, Semmes OJ, Feliberti EC, Perry RR, Drake RR.

J Am Coll Surg. 2009 May;208(5):970-8; discussion 978-80. doi: 10.1016/j.jamcollsurg.2008.12.024. Epub 2009 Mar 26.

PMID:
19476873
31.

Precision enhancement of MALDI-TOF MS using high resolution peak detection and label-free alignment.

Tracy MB, Chen H, Weaver DM, Malyarenko DI, Sasinowski M, Cazares LH, Drake RR, Semmes OJ, Tracy ER, Cooke WE.

Proteomics. 2008 Apr;8(8):1530-8. doi: 10.1002/pmic.200701146.

32.

MALDI/SELDI protein profiling of serum for the identification of cancer biomarkers.

Cazares LH, Diaz JI, Drake RR, Semmes OJ.

Methods Mol Biol. 2008;428:125-40.

PMID:
18287771
33.

Tissue sample collection for proteomics analysis.

Diaz JI, Cazares LH, Semmes OJ.

Methods Mol Biol. 2008;428:43-53.

PMID:
18287767
34.

Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.

Freed GL, Cazares LH, Fichandler CE, Fuller TW, Sawyer CA, Stack BC Jr, Schraff S, Semmes OJ, Wadsworth JT, Drake RR.

Laryngoscope. 2008 Jan;118(1):61-8.

PMID:
18043497
35.

SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer.

McLerran D, Grizzle WE, Feng Z, Thompson IM, Bigbee WL, Cazares LH, Chan DW, Dahlgren J, Diaz J, Kagan J, Lin DW, Malik G, Oelschlager D, Partin A, Randolph TW, Sokoll L, Srivastava S, Srivastava S, Thornquist M, Troyer D, Wright GL, Zhang Z, Zhu L, Semmes OJ.

Clin Chem. 2008 Jan;54(1):53-60. Epub 2007 Nov 16.

36.

Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias.

McLerran D, Grizzle WE, Feng Z, Bigbee WL, Banez LL, Cazares LH, Chan DW, Diaz J, Izbicka E, Kagan J, Malehorn DE, Malik G, Oelschlager D, Partin A, Randolph T, Rosenzweig N, Srivastava S, Srivastava S, Thompson IM, Thornquist M, Troyer D, Yasui Y, Zhang Z, Zhu L, Semmes OJ.

Clin Chem. 2008 Jan;54(1):44-52. Epub 2007 Nov 2.

37.

Optimization of MALDI-TOF MS detection for enhanced sensitivity of affinity-captured proteins spanning a 100 kDa mass range.

Gatlin-Bunai CL, Cazares LH, Cooke WE, Semmes OJ, Malyarenko DI.

J Proteome Res. 2007 Nov;6(11):4517-24. Epub 2007 Oct 5.

38.

Discrete serum protein signatures discriminate between human retrovirus-associated hematologic and neurologic disease.

Semmes OJ, Cazares LH, Ward MD, Qi L, Moody M, Maloney E, Morris J, Trosset MW, Hisada M, Gygi S, Jacobson S.

Leukemia. 2005 Jul;19(7):1229-38.

PMID:
15889159
39.

Measurement reproducibility in the early stages of biomarker development.

Liggett WS, Barker PE, Semmes OJ, Cazares LH.

Dis Markers. 2004;20(6):295-307.

40.

Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.

Semmes OJ, Feng Z, Adam BL, Banez LL, Bigbee WL, Campos D, Cazares LH, Chan DW, Grizzle WE, Izbicka E, Kagan J, Malik G, McLerran D, Moul JW, Partin A, Prasanna P, Rosenzweig J, Sokoll LJ, Srivastava S, Srivastava S, Thompson I, Welsh MJ, White N, Winget M, Yasui Y, Zhang Z, Zhu L.

Clin Chem. 2005 Jan;51(1):102-12.

41.

Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer.

Becker S, Cazares LH, Watson P, Lynch H, Semmes OJ, Drake RR, Laronga C.

Ann Surg Oncol. 2004 Oct;11(10):907-14. Epub 2004 Sep 20.

PMID:
15383419
42.

Selective capture of prostatic basal cells and secretory epithelial cells for proteomic and genomic analysis.

Diaz JI, Cazares LH, Corica A, John Semmes O.

Urol Oncol. 2004 Jul-Aug;22(4):329-36.

PMID:
15283892
43.

Serum protein profiles to identify head and neck cancer.

Wadsworth JT, Somers KD, Cazares LH, Malik G, Adam BL, Stack BC Jr, Wright GL Jr, Semmes OJ.

Clin Cancer Res. 2004 Mar 1;10(5):1625-32.

44.

Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures.

Wright GL Jr, Cazares LH, Leung SM, Nasim S, Adam BL, Yip TT, Schellhammer PF, Gong L, Vlahou A.

Prostate Cancer Prostatic Dis. 1999 Dec;2(5-6):264-276.

45.

Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients.

Qu Y, Adam BL, Yasui Y, Ward MD, Cazares LH, Schellhammer PF, Feng Z, Semmes OJ, Wright GL Jr.

Clin Chem. 2002 Oct;48(10):1835-43.

46.
47.

Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes OJ, Schellhammer PF, Yasui Y, Feng Z, Wright GL Jr.

Cancer Res. 2002 Jul 1;62(13):3609-14.

48.

Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease.

Xiao Z, Adam BL, Cazares LH, Clements MA, Davis JW, Schellhammer PF, Dalmasso EA, Wright GL Jr.

Cancer Res. 2001 Aug 15;61(16):6029-33.

49.

Overexpression of p53 in prostate carcinoma is associated with improved overall survival but not predictive of response to radiotherapy.

Incognito LS, Cazares LH, Schellhammer PF, Kuban DA, Van Dyk EO, Moriarty RP, Wright GL Jr, Somers KD.

Int J Oncol. 2000 Oct;17(4):761-9.

PMID:
10995889
50.

Identification of a superimmunoglobulin gene family member overexpressed in benign prostatic hyperplasia .

Wright GL Jr, Beckett ML, Newhall KR, Adam BL, Cazares LH, Cartwright SL, Xiao Z, Gong L, Schellhammer PF.

Prostate. 2000 Feb 15;42(3):230-8.

PMID:
10639194

Supplemental Content

Loading ...
Support Center